Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Carmat elects heart industry veterans to board

This article was originally published in Clinica

Executive Summary

Carmat, a Velizy, France-based start-up developing a fully-implantable artificial heart for late-stage heart failure patients, has expanded its board of directors with three new members. They are: André-Michel Ballester, CEO of Italian cardiovascular device company Sorin; Peter Steinmann, former vice-president of Medtronic, and Michel Finance, acting CEO of Carmat. This brings the total number of board directors to six. The other members include chairman Jean-Claude Cadudal, founder and chief scientific officer Professor Alain Carpentier, and general partner of Truffle Capital, Dr Philippe Pouletty.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044193

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel